Vaxcyte Inc.
PCVX | NASDAQ
$59.24
+$0.32 (+0.54%)
Sep 22, 2026, 11:29 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 865K | 5.85M | n/a | 4.99M | 4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -865K | -5.85M | n/a | -4.99M | -4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.17B | -1.09B | -923.68M | -811.56M | -709.11M | -635.87M | -569.55M | -604.05M | -577.16M | -511.32M | -468.04M | -357.94M | -303.49M | -264.23M | -232.26M | -175.53M | -143.9M | -119.75M | -103.67M | -93.28M | -87.63M | -85.13M |
Interest Income | 108.08M | 113.39M | 119.72M | 129.73M | 128.52M | 121.26M | 109.99M | 91.1M | 81.54M | 74.18M | 62.91M | 51.97M | 34.67M | 18.62M | 8.36M | 1.82M | 722K | 416K | 343K | 276K | 219K | 170K |
Pretax Income | -1.06B | -946.53M | -766.63M | -657.2M | -547.5M | -509.63M | -463.93M | -507.65M | -497.19M | -436.82M | -402.27M | -299.52M | -264.77M | -244.96M | -223.49M | -174M | -142.7M | -117.84M | -100.08M | -92.25M | -86.65M | -83.3M |
Net Income | -1.06B | -946.53M | -766.63M | -657.2M | -547.5M | -509.63M | -463.93M | -507.65M | -497.19M | -436.82M | -402.27M | -299.52M | -264.77M | -244.96M | -223.49M | -174M | -142.7M | -117.84M | -100.08M | -92.25M | -86.65M | -83.3M |
Selling & General & Admin | 132.67M | 129.78M | 129.37M | 125.7M | 116.24M | 105.68M | 92.9M | 81.87M | 74.49M | 67.47M | 60.7M | 55.13M | 50.42M | 45.38M | 39.81M | 34.63M | 30.26M | 26.92M | 25.26M | 23.28M | 21.65M | 18.62M |
Research & Development | 1.03B | 958.95M | 794.31M | 685.86M | 592.86M | 530.19M | 476.64M | 447.18M | 427.67M | 368.85M | 332.34M | 279.82M | 230.08M | 195.85M | 169.45M | 140.9M | 113.65M | 92.83M | 78.41M | 70M | 65.98M | 66.51M |
Other Expenses | -865K | -5.85M | n/a | -4.99M | -4.99M | n/a | n/a | 75M | 75M | 75M | 75M | 23M | 23M | 23M | 23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.16B | 1.08B | 923.68M | 806.57M | 704.12M | 635.87M | 569.55M | 604.05M | 577.16M | 511.32M | 468.04M | 357.94M | 303.49M | 264.23M | 232.26M | 175.53M | 143.9M | 119.75M | 103.67M | 93.28M | 87.63M | 85.13M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K | 2K | 7K | 7K | 7K | 7K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.17B | 1.09B | 923.68M | 811.56M | 709.11M | 635.87M | 569.55M | 604.05M | 577.16M | 511.32M | 468.04M | 357.94M | 303.49M | 264.23M | 232.26M | 175.53M | 143.9M | 119.75M | 103.67M | 93.28M | 87.63M | 85.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 144.49M | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M | 86.21M | 75.54M | 61.99M | 60.82M | 57.55M | 54.73M | 52.19M | 51.51M | 51.17M |
Shares Outstanding (Diluted) | 144.49M | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M | 86.21M | 75.54M | 61.99M | 60.82M | 57.55M | 54.73M | 52.19M | 51.51M | 51.17M |
EPS (Basic) | -7.64 | -6.89 | -5.63 | -4.94 | -4.21 | -4.09 | -3.90 | -4.51 | -4.59 | -4.19 | -4.04 | -3.34 | -3.36 | -3.46 | -3.44 | -2.93 | -2.51 | -2.17 | -1.90 | -1.79 | -1.69 | -1.65 |
EPS (Diluted) | -7.64 | -6.89 | -5.63 | -4.94 | -4.21 | -4.09 | -3.90 | -4.51 | -4.59 | -4.19 | -4.04 | -3.34 | -3.36 | -3.46 | -3.44 | -2.93 | -2.51 | -2.17 | -1.90 | -1.79 | -1.69 | -1.65 |
EBITDA | -1.05B | -920.69M | -741.77M | -559.77M | -485.15M | -448.79M | -404.87M | -530.15M | -503.91M | -460.97M | -437.24M | -335.13M | -281.79M | -245.87M | -214.36M | -165.97M | -136.17M | -112.61M | -98.54M | -91.58M | -86.51M | -83.67M |
EBIT | -1.08B | -946.53M | -766.63M | -577.48M | -504.29M | -466.42M | -420.72M | -544.16M | -515.91M | -471.89M | -447.41M | -344.66M | -291.19M | -255.04M | -223.56M | -174.07M | -142.77M | -117.91M | -101.99M | -94.17M | -88.57M | -85.22M |
Depreciation & Amortization | 23.85M | 25.84M | 24.86M | 17.71M | 19.14M | 17.63M | 15.85M | 14.01M | 12M | 10.92M | 10.17M | 9.52M | 9.4M | 9.17M | 9.2M | 8.1M | 6.6M | 5.3M | 3.46M | 2.58M | 2.06M | 1.55M |
Add to Watchlist
Select watchlists to add or remove PCVX